300
Participants
Start Date
September 1, 2024
Primary Completion Date
December 30, 2026
Study Completion Date
January 30, 2027
Recombinant Human Follitropin Alfa Solution for Injection (Gonal-f®)
As a r-hFSH agent, Gonal-f® is used for COS. It is a prefilled ready to use pen device containing follitropin alfa for injection and is designed for subcutaneous self-administration by patients undergoing COS for ART. It is available as dose presentations of 150 IU and 450 IU. The investigators and/or his/her delegate/s will explain the use of Gonal-f® prefilled pen. Gonal-f® will be prescribed by the investigator based on clinical diagnosis and treatment routines, and will not be provided free of charge.
Recombinant Human Lutropin alfa for Injection (r-hLH, Luveris®)
This product is a white freeze-dried powder and a colorless and clear injection solvent, and stored away from light under 25℃ in the original packaging. Luveris® will be provided free of charge.
Nanjing Drum Tower Hospital, Nanjing
Nanjing University
OTHER